Grard Soula, Chairman and Co-founder of Adocia, from the Board of Directors and co-opted Mr
BPC-157 is supplied by NuRev Peptides strictly for laboratory research and testing purposes
Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
Learn about MASLD benefits and enzyme monitoring
You are solely responsible for determining whether you may lawfully purchase, import, possess, store, transfer, and use each product in your jurisdiction and research setting
While these side effects are relatively rare, they highlight the need for thorough clinical evaluations and monitoring